Aspirin to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

Platelets seem to be hyper-reactive in Covid-19 and may be involved in the observed clotting complications. Aspirin will now be investigated in patients hospitalised with Covid-19 in the RECOVERY trial, with at least 2,000 patients randomly allocated to receive 150mg daily.

Reuters Health